$2.47
0.12[5.11%]
At close: Apr 22
$2.47
0[0.00%]
PreMarket: 7:56PM EDT
Oramed Pharmaceuticals
(NASDAQ:ORMP)Oramed Pharmaceuticals Stock (NASDAQ:ORMP), Earnings Estimates, EPS, and Revenue
Oramed Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 9
EPS Estimate
$0.020
Quarterly Revenue Estimate
$500K
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$1.3M
Analyze the earnings history of Oramed Pharmaceuticals using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 05/09/2024 | PM | ORMP | Q1 | -$0.08 | $0.02 | — | — | $666.00K | $500.00K | — | — | Get Alert |
| 03/06/2024 | PM | ORMP | Q4 | $0.22 | -$0.12 | $0.33 | 375.00% | $681.00K | $0.00 | $0.00 | — | Get Alert |
| 11/09/2023 | PM | ORMP | Q3 | -$0.18 | -$0.08 | -$0.08 | 0.00% | $682.00K | $700.00K | $0.00 | -100.00% | Get Alert |
| 08/10/2023 | PM | ORMP | Q2 | -$0.27 | -$0.11 | -$0.03 | 72.73% | $1.34M | $700.00K | $674.00K | -3.71% | Get Alert |
| 05/11/2023 | PM | ORMP | Q1 | -$0.27 | -$0.26 | -$0.08 | 69.23% | $666.00K | $750.00K | $666.00K | -11.20% | Get Alert |
| 03/06/2023 | PM | ORMP | Q4 | -$0.21 | -$0.19 | $0.22 | 215.79% | $683.00K | $2.95M | $681.00K | -76.92% | Get Alert |
| 11/10/2022 | PM | ORMP | Q3 | -$0.17 | -$0.25 | -$0.18 | 28.00% | $681.00K | $690.00K | $682.00K | -1.16% | Get Alert |
| 08/10/2022 | PM | ORMP | Q2 | -$0.17 | -$0.22 | -$0.27 | -22.73% | $665.00K | — | $674.00K | — | Get Alert |
| 05/12/2022 | PM | ORMP | Q1 | -$0.23 | -$0.23 | -$0.27 | -17.39% | $674.00K | — | $666.00K | — | Get Alert |
| 01/11/2022 | PM | ORMP | Q1 | -$0.23 | -$0.16 | -$0.22 | -37.50% | $674.00K | $700.00K | $674.00K | -3.71% | Get Alert |
| 11/24/2021 | PM | ORMP | Q4 | -$0.10 | -$0.10 | -$0.21 | -110.00% | $681.00K | — | $683.00K | — | Get Alert |
| 07/14/2021 | PM | ORMP | Q3 | $0.10 | -$0.20 | -$0.17 | 15.00% | $681.00K | $970.00K | $681.00K | -29.79% | Get Alert |
| 04/13/2021 | PM | ORMP | Q2 | -$0.21 | -$0.19 | -$0.17 | 10.53% | $674.00K | — | $665.00K | — | Get Alert |
| 01/14/2021 | PM | ORMP | Q1 | -$0.15 | -$0.14 | -$0.23 | -64.29% | $674.00K | $640.00K | $674.00K | 5.31% | Get Alert |
| 11/24/2020 | AM | ORMP | Q4 | -$0.23 | -$0.15 | -$0.10 | 33.33% | $681.00K | — | $681.00K | — | Get Alert |
| 07/07/2020 | PM | ORMP | Q3 | -$0.23 | -$0.15 | -$0.10 | 33.33% | $682.00K | — | $681.00K | — | Get Alert |
| 04/06/2020 | PM | ORMP | Q2 | -$0.21 | -$0.25 | -$0.21 | 16.00% | $666.00K | — | $674.00K | — | Get Alert |
| 01/09/2020 | PM | ORMP | Q1 | -$0.25 | -$0.26 | -$0.15 | 42.31% | $674.00K | — | $674.00K | — | Get Alert |
| 11/27/2019 | PM | ORMP | Q4 | -$0.18 | -$0.34 | -$0.23 | 32.35% | $617.00K | — | $681.00K | — | Get Alert |
FAQ
When is Oramed Pharmaceuticals (NASDAQ:ORMP) reporting earnings?
Oramed Pharmaceuticals (ORMP) is scheduled to report earnings on May 9, 2024. The last reported earnings were for reported on March 6, 2024 for Q4.
What were the latest earnings per share (EPS) for Oramed Pharmaceuticals (NASDAQ:ORMP)?
The Actual EPS was $0.33, which beat the estimate of $-0.12.
What were Oramed Pharmaceuticals’s (NASDAQ:ORMP) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.